Open randomised study for evaluation of an active hepatitis B vaccination (HBvaxPRO) in combination with a passive immunisation with hepatitis B immunoglobulins (Hepatect) for subjects who did not show any or an adequate reaction to a previous sole active hepatitis B immunisation.
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2012
At a glance
- Drugs Hepatitis B immune globulin (Primary) ; Hepatitis B vaccine recombinant (HBvaxPro) (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- Acronyms PAI-Study
- 12 Apr 2012 Actual initiation date changed from 1 Aug 2008 to 2 Apr 2008 as reported as reported by European Clinical Trials Database.
- 18 Jun 2011 Last checked against ISRCTN: Current Controlled Trials record.
- 23 Oct 2008 New trial record.